Actively Recruiting
Black Rice Consumption on Cognitive Function, Inflammation and Microvascular Function in Older Adults
Led by University of Reading · Updated on 2024-09-04
24
Participants Needed
2
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cognitive (brain) function, especially memory, gradually declines during ageing, which may in part be caused by an increase in systemic inflammation as well as a reduction in vascular functions and cerebral blood flow. Blood inflammatory mediators such as c-reactive protein (CRP) and interleukin-6 (IL-6) found to be significantly higher among people over 65 years compared to younger age groups. Anthocyanins is water-soluble compounds giving blue, purple and red colours in fruits and vegetables. Anthocyanins have been demonstrated to improve cognitive function, inhibit inflammation, and protect cardiovascular health. Black rice contains high amounts of anthocyanins mainly cyanidin 3-glucoside and peonidin 3-glucoside as well as various nutritional compounds such as carbohydrate, vitamin B, vitamin E and fibre. Previous studies reported health benefits of black rice, including anti-inflammation, antioxidative stress, anti-diabetes, and improved cognitive function. However, the effect of black rice consumption on cognitive function related to inflammation has not been studied in humans. Therefore, this study aims evaluate the acute \& short-term effects of black rice consumption on the cognitive function, inflammation, and vascular function in older adults aged 50-80 years. The primary and secondary research questions of this study will address: 1. Do the acute and short-term anthocyanin-rich black rice intakes improve cognitive function in older adults aged 50-80 years? 2. Do the acute and short-term anthocyanin-rich black rice intakes modulate inflammatory status and microvascular function in older adults aged 50-80 years?
CONDITIONS
Official Title
Black Rice Consumption on Cognitive Function, Inflammation and Microvascular Function in Older Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 50-80 years
- General healthy status
- Body Mass Index (BMI) 18.5-35 kg/m2
You will not qualify if you...
- Taking anti-inflammatory drugs (e.g., aspirin, warfarin, ibuprofen)
- Having signs of infections or acute inflammation (e.g., fever, chills, sore throat, nasal congestion, moderate-severe pain, swelling-redness)
- Received antibiotics within the past 3 months
- Taking dietary supplements at high doses (more than 200% of the UK's reference nutrient intakes)
- Taking hormone replacement therapy if menopausal
- Had major surgery (head, heart, chest, abdomen) within the past 6 months
- Planning to start a restricted diet, change dietary pattern, or lose weight
- Diagnosed with neurodegenerative diseases (e.g., Dementia, Alzheimer's, Parkinson's, current stroke)
- Diagnosed with psychotic disorders (e.g., schizophrenia, bipolar depression, eating disorder)
- Diagnosed with cardiovascular disease, diabetes, hyperlipidemia, hypertension (blood pressure >140/90 mmHg), active cancer, liver, or kidney diseases
- Taking medication to lower blood fats or stabilize blood glucose or lower blood pressure
- Unable to complete cognitive function tasks due to issues like visual or hearing impairments
- Having a pacemaker
- Having bleeding disorders or blood-related diseases (e.g., anemia, thalassemia, thrombosis, embolism)
- Heavy smoker
- Heavy alcohol drinking (>14 units/week) or history of alcohol/substance abuse
- Allergies, hypersensitivity, or food intolerances to rice, eggs, soy sauce, or vegetable oil
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hugh Sinclair Unit of Human Nutrition
Reading, UK, United Kingdom, RG2 6AP
Actively Recruiting
2
Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading
Reading, United Kingdom, RG2 6AP
Actively Recruiting
Research Team
J
Jeremy Spencer, PhD
CONTACT
C
Chusana Mekhora, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here